Evidence map›Paper›PMID 36768864›Full record

ArticleInternational journal of molecular sciences2023

Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-Resistant

Sara Scutera, Rosaria Sparti, Sara Comini, Francesca Menotti, Tiziana Musso, Anna Maria Cuffini, Valeria Allizond, Giuliana Banche

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara ScuteraDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.ORCID 0000-0002-7431-0875
Rosaria SpartiDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.
Sara CominiDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.
Francesca MenottiDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.
Tiziana MussoDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.
Anna Maria CuffiniDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.
Valeria AllizondDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.ORCID 0000-0003-0585-9247
Giuliana BancheDepartment of Public Health and Pediatrics, University of Torino, 10125 Turin, Italy.ORCID 0000-0003-2219-0223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphonuclear leukocytes (PMNs) are the most important cell type involved in the early nonspecific host response to bacterial pathogens.

Indexed as

Anti-Infective AgentsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsHumansNeutrophilsStaphylococcus aureusTeicoplaninAnti-Bacterial AgentsAnti-Infective AgentsdalbavancinTeicoplaninapoptosiscytokine releasedalbavancinintracellular killing activitymethicillin-resistant Staphylococcus aureusneutrophil extracellular trapspolymorphonuclear leukocytesreactive oxygen species production

Identifiers

PMID36768864
PMCPMC9917267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.